WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alistair MilnesCHIEF OPERATING OFFICER2025-04-031,038$7.48
$7.76kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2025-04-03109$7.48
$815.32Sell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2025-04-03266$7.48
$1.99kSell
Michael SkynnerCHIEF TECHNOLOGY OFFICER2025-04-031,038$7.48
$7.76kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2025-04-033,432$7.48
$25.67kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2025-04-02210$8.02
$1.68kSell
Alethia YoungChief Financial Officer2025-04-02215$8.02
$1.72kSell
Michael SkynnerCHIEF TECHNOLOGY OFFICER2025-04-02814$8.02
$6.53kSell
Alistair MilnesCHIEF OPERATING OFFICER2025-04-021,133$8.02
$9.09kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2025-04-022,237$8.02
$17.94kSell

1 of 6

BCYC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP15.72%10,885,357$94.59MInstitution
Baker Bros Advisors LP14.44%9,999,674$86.90MInsider
Point72 Asset Management LP5.33%3,692,069$32.08MInstitution
Fcpm III Services Bv4.99%3,452,330$30.00MInstitution
Armistice Capital LLC3.86%2,672,000$23.22MInstitution
Westfield Capital Management Co LP3.84%2,657,305$23.09MInstitution
Carolyn Ng2.89%1,998,580$17.37MInsider
Tybourne Capital Management Hk Ltd2.83%1,957,961$17.01MInsider
Deborah Harland2.77%1,915,275$16.64MInsider
Svlsf V LLC2.77%1,915,274$16.64MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC58.22%41.78%Net BuyingNet Selling
SANA51.20%48.80%Net Selling
MAZE83.38%16.62%
NUVB56.62%43.38%Net BuyingNet Buying
DNTH52.83%47.17%
View Top Biotech Stocks

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 60.26% institutional shareholders, 43.24% Bicycle Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 10.00M shares representing 14.44% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $83.70M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.